MSWA is proud to be Western Australia’s leading contributor to neurological research
Over the past 10 years, MSWA has funded over $20 million towards local, national and international research projects.
We believe that by doing so, we are one step closer to finding the cause, better treatments and hopefully one day a cure for neurological conditions.
Thanks to our investment into research, understanding of neurological conditions has significantly improved over the years. This investment would not be possible without Western Australians supporting our fundraising initiatives which allow MSWA funded researchers to continue their important work.
CURRENT MSWA FUNDED RESEARCH
The Perron Institute - Led by Group Director and Clinical Professor Allan Kermode
The most common type of demyelinating diseases is MS. The group at the Perron Institute are conducting a diverse range of studies that are scientifically related with topics strategically designed to interlink.
Subjects include biomarkers, the use of quantitative MRI assessment, the inter-related effects of environment and immunogenetics, effects of UVB phototherapy, the role of antibodies and B-cells in MS and T-cell immune targets in immediate post-mortem MS.
Trajectories of Outcome in Neurological Conditions
The Perron Institute - led by Head of Genetic Epidemiology Research Professor Sulev Kōks
This study examines the factors that influence the quality of life for people living with a neurological condition from their perspective. It originated in the UK and is the largest study of its kind in the world.
The Perron Institute and Murdoch University – This research is a collaboration between Dr Ryan Anderton and Dr Luke Whiley
This study investigates gut bacteria and how they disrupt the balance between the gastrointestinal system, the immune system and the brain for those living with Parkinson’s disease (PD).
The study explores short-chain fatty acids, a by-product of bacterial digestion of fibre in the colon, to understand key mechanisms and biomarkers associated with PD. This study may well be relevant for other neurological conditions.
Telethon Kids Institute – Led by Professor Prue Hart
This study looks into the effects of UVB treatment in delaying the development of MS in high-risk individuals. As an extension of this project, MSWA is funding further analysis on different components of the blood samples collected and stored in the biobank at the Telethon Institute.
MSWA is proud to fund the International Progressive MS Alliance through MSRA, working towards finding a greater understanding and better treatments for progressive MS
MSWA is proud to fund the International Progressive MS Alliance. This is an unprecedented global collaboration of MS organisations, researchers, clinicians, pharmaceutical companies, and people with progressive MS, striving to create a better understanding of the progressive process and accelerate access to treatments for people living with progressive MS.
MSWA has allocated $1.7M (up to 2019/2020) to this Alliance and there will be an additional $1M this financial year.